![]() Hypercalcemia may aggravate digitalis toxicity. Severe hypercalcemia may require hemodialysis and discontinuation of Caltrate + D (Calcium (Calcium Carbonate)) acetate. Treat mild hypercalcemia by reducing or interrupting Caltrate + D ) acetate and Vitamin D. Capsule: 667 mg Caltrate + D (Calcium (Calcium Carbonate)) acetate capsule. (2)Ĭapsule: 667 mg Caltrate + D (Calcium (Calcium Carbonate)) acetate capsule. Most patients require 3 to 4 capsules with each meal. Titrate the dose every 2 to 3 weeks until acceptable serum phosphorus level is reached. ![]() Starting dose is 2 capsules with each meal. Increase the dose gradually to lower serum phosphorus levels to the target range, as long as hypercalcemia does not develop. The recommended initial dose of Caltrate + D (Calcium (Calcium Carbonate)) acetate for the adult dialysis patient is 2 capsules with each meal. Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. Caltrate + D (Calcium (Calcium Carbonate)) acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |